These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The impact of pharmacogenetics on the development and use of antipsychotic drugs. Reynolds GP Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414 [TBL] [Abstract][Full Text] [Related]
4. The future of drugs. Elmer-DeWitt P Time; 2001 Jan; 157(2):56-7. PubMed ID: 11195689 [No Abstract] [Full Text] [Related]
5. Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care? Hopkins MM; Martin PA Expert Rev Neurother; 2006 Dec; 6(12):1765-7. PubMed ID: 17181421 [No Abstract] [Full Text] [Related]
6. Pharmacogenetics in drug discovery and development: a translational perspective. Roses AD Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753 [TBL] [Abstract][Full Text] [Related]
7. Challenges of drug discovery for personalized medicine. Jain KK Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483 [TBL] [Abstract][Full Text] [Related]
8. Target practice: oncology drug development in the era of genomic medicine. Schilsky RL Clin Trials; 2007; 4(2):163-6; discussion 173-7. PubMed ID: 17456516 [No Abstract] [Full Text] [Related]
9. [Customized drug therapy--how near is the goal?]. Spigset O Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2390-6. PubMed ID: 16998553 [TBL] [Abstract][Full Text] [Related]
10. Implications of pharmacogenomics for drug development. Kirk RJ; Hung JL; Horner SR; Perez JT Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics: using DNA to optimize drug therapy. Lanfear DE; McLeod HL Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842 [TBL] [Abstract][Full Text] [Related]
12. The Affymetrix DMET platform and pharmacogenetics in drug development. Deeken J Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659 [TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450s in the development of target-based anticancer drugs. Purnapatre K; Khattar SK; Saini KS Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638 [TBL] [Abstract][Full Text] [Related]
14. Bridging the knowledge gaps in vaccine design. Rappuoli R Nat Biotechnol; 2007 Dec; 25(12):1361-6. PubMed ID: 18066025 [No Abstract] [Full Text] [Related]
15. CNVs of human genes and their implication in pharmacogenetics. Johansson I; Ingelman-Sundberg M Cytogenet Genome Res; 2008; 123(1-4):195-204. PubMed ID: 19287156 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies. Anglicheau D; Legendre C; Thervet E Transplant Proc; 2007 Sep; 39(7):2142-4. PubMed ID: 17889118 [TBL] [Abstract][Full Text] [Related]
17. In silico prediction of clinical efficacy. Michelson S; Sehgal A; Friedrich C Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236 [TBL] [Abstract][Full Text] [Related]